van Wijk DF - Search Results

1

C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study.

van Wijk DF, Boekholdt SM, Arsenault BJ, Ahmadi-Abhari S, Wareham NJ, Stroes ES, Khaw KT. van Wijk DF, et al. J Am Heart Assoc. 2016 Jun 3;5(6):e002823. doi: 10.1161/JAHA.115.002823. J Am Heart Assoc. 2016. PMID: 27260511 Free PMC article.

2

C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.

van Wijk DF, Boekholdt SM, Wareham NJ, Ahmadi-Abhari S, Kastelein JJ, Stroes ES, Khaw KT. van Wijk DF, et al. Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2888-94. doi: 10.1161/ATVBAHA.113.301736. Epub 2013 Sep 26. Arterioscler Thromb Vasc Biol. 2013. PMID: 24072695

3

Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.

van Wijk DF, van Leuven SI, Sandhu MS, Tanck MW, Hutten BA, Wareham NJ, Kastelein JJ, Stroes ES, Khaw KT, Boekholdt SM. van Wijk DF, et al. Among authors: van leuven si. Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1460-6. doi: 10.1161/ATVBAHA.110.205526. Epub 2010 Apr 29. Arterioscler Thromb Vasc Biol. 2010. PMID: 20431065 Free PMC article.

4

Lipid measures and cardiovascular disease prediction.

van Wijk DF, Stroes ES, Kastelein JJ. van Wijk DF, et al. Dis Markers. 2009;26(5-6):209-16. doi: 10.3233/DMA-2009-0636. Dis Markers. 2009. PMID: 19773610 Free PMC article. Review.

5

Novel insights into anti-inflammatory actions of HDL.

van Wijk DF, Stroes ES, Dallinga-Thie GM. van Wijk DF, et al. Atherosclerosis. 2010 Oct;212(2):388-9. doi: 10.1016/j.atherosclerosis.2010.06.032. Epub 2010 Jul 3. Atherosclerosis. 2010. PMID: 20650459 No abstract available.

6

Improving risk stratification for cardiovascular disease.

van Wijk DF, Boekholdt SM. van Wijk DF, et al. Expert Rev Cardiovasc Ther. 2010 Aug;8(8):1091-3. doi: 10.1586/erc.10.71. Expert Rev Cardiovasc Ther. 2010. PMID: 20670186

7

Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors.

Broekhuizen LN, van Wijk DF, Vink H, Stalmach A, Crozier A, Hutten BA, Kastelein JJ, Hugenholtz PG, Koenig W, Stroes ES. Broekhuizen LN, et al. Among authors: van wijk df. Br J Nutr. 2011 Nov;106(9):1416-22. doi: 10.1017/S0007114511002431. Epub 2011 Jun 28. Br J Nutr. 2011. PMID: 21733322 Clinical Trial.

8

ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden.

Bochem AE, van Wijk DF, Holleboom AG, Duivenvoorden R, Motazacker MM, Dallinga-Thie GM, de Groot E, Kastelein JJ, Nederveen AJ, Hovingh GK, Stroes ES. Bochem AE, et al. Among authors: van wijk df. Eur Heart J. 2013 Jan;34(4):286-91. doi: 10.1093/eurheartj/ehs376. Epub 2012 Nov 7. Eur Heart J. 2013. PMID: 23136402

9

Dalcetrapib: turning the tide for CETP inhibition?

Stroes ES, van Wijk DF. Stroes ES, et al. Among authors: van wijk df. Lancet. 2011 Oct 29;378(9802):1529-30. doi: 10.1016/S0140-6736(11)61421-9. Epub 2011 Sep 9. Lancet. 2011. PMID: 21908039 No abstract available.

10

Novel anti-inflammatory strategies in atherosclerosis.

van der Valk FM, van Wijk DF, Stroes ES. van der Valk FM, et al. Among authors: van wijk df. Curr Opin Lipidol. 2012 Dec;23(6):532-9. doi: 10.1097/MOL.0b013e3283587543. Curr Opin Lipidol. 2012. PMID: 23160400 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page